October 28, 2016 1:15 AM ET

Company Overview of Broad Institute of MIT and Harvard

Company Overview

7 Cambridge Center

Cambridge, MA 02142

United States





Key Executives for Broad Institute of MIT and Harvard

President and Founding Director
Age: 59
Associate Member and Director of Stanley Center for Psychiatric Research
Age: 75
Compensation as of Fiscal Year 2016.

Broad Institute of MIT and Harvard Key Developments

Monsanto Enters into Licensing Agreement with Broad Institute of MIT and Harvard for the Use of the CRISPR-Cas Genome-Editing Technology in Agriculture

Monsanto Company has entered into a global licensing agreement for the use of the CRISPR-Cas genome-editing technology in agriculture with the Broad Institute of MIT and Harvard. Under the agreement, the Broad Institute grants Monsanto a worldwide non-exclusive license for agriculture applications of the CRISPR-Cas technology.

AMRI Enters into Non-Exclusive Commercial License Agreement with Broad Institute of MIT and Harvard for the Use of CRISPR-Cas9 Gene Editing Technology

AMRI announced that it entered into a non-exclusive commercial license agreement with the Broad Institute of MIT and Harvard for the use of CRISPR-Cas9 gene editing technology and has completed several projects for its customers. The company will continue to use the technology to enhance its drug discovery service offerings and internal research and development. The CRISPR/Cas system serves as a naturally-occurring bacterial immune system that confers resistance to foreign genetic elements such as those from viruses. It has been developed as a precise method for editing the genetic code in mammalian cells, which allows researchers to effectively knock out or enhance the expression of targeted genes. It offers great utility in the development of in vivo and in vitro disease models, which are important for drug discovery research. Under the terms of the commercial use license, AMRI gained access to IP related to CRISPR-Cas9 technology that is being used to enhance AMRI's drug discovery services offerings and associated client programs. The application of CRISPR-Cas9 technology benefits a number of the specific services that AMRI provides to its customers, including protein production, cell line and assay development, high content screening and analysis, and target validation and assessment.

Evotec Enters Licence Agreement for Access to CRISPR-CAS9 Gene Editing Technology

Evotec AG announced that it has entered into a non-exclusive licence agreement with the Broad Institute of MIT and Harvard for the use of CRISPR-Cas9 gene editing technology. Under the terms of this research tool licence, company gains access to IP related to CRISPR-Cas9 and will apply the technology to its drug discovery offerings and R&D activities, especially for the development of research tools and in target identification, and to further strengthen its post phenotypical screening target deconvolution platform. With this agreement, Evotec obtains non-exclusive access to the leading technology on the market for gene editing.

Similar Private Companies By Industry

Company Name Region
Aryzta Us Holdings I Corp. United States
!SOLUTIONS! Group United States
"Atlantic Tele-Satellite, Inc. United States
"D" Construction, Inc. United States
"Graham & Associates,Inc" United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
The Advertising Council, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Broad Institute of MIT and Harvard, please visit www.broadinstitute.org. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.